Tinostamustine and Nivolumab in Advanced Melanoma
Clinical trial NCT03903458 · UNKNOWN
Trial details
- NCT number
- NCT03903458
- Sponsor
- Markus Joerger
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-07
- Primary completion
- 2021-12-15
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.